Ohio Public Employees Retirement System (OPERS)’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.1K Hold
7,651
﹤0.01% 1907
2025
Q4
$46.9K Hold
7,651
﹤0.01% 1972
2025
Q3
$141K Sell
7,651
-10,780
-58% -$173K ﹤0.01% 1736
2025
Q2
$240K Buy
+18,431
New +$218K ﹤0.01% 1621
2024
Q4
Sell
-4,356
Closed -$101K 2353
2024
Q3
$101K Hold
4,356
﹤0.01% 1634
2024
Q2
$106K Sell
4,356
-264
-6% -$8.01K ﹤0.01% 1424
2024
Q1
$156K Buy
4,620
+1,800
+64% +$63.8K ﹤0.01% 1380
2023
Q4
$88.9K Buy
+2,820
New +$67K ﹤0.01% 1441

Other funds holding ARCT

Ohio Public Employees Retirement System (OPERS)'s ARCT Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) held its Arcturus Therapeutics (ARCT) position steady in Q1 2026 at 7,651 shares worth $59.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Ohio Public Employees Retirement System (OPERS) first reported a position in ARCT in Q4 2023 and has held it in 8 quarters since. The position peaked at $240K in Q2 2025. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 7,651 shares of Arcturus Therapeutics worth $59.1K as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) left its Arcturus Therapeutics share count unchanged in Q1 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1907 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Arcturus Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Arcturus Therapeutics position peaked at $240K in Q2 2025.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.